Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Revenues:
Total revenues	$ 824,268	$ 2,359,447
Cost of revenues	(728,640)	(1,820,949)
Gross Profit	95,628	538,498
Operating expenses:
Research and development	8,389,387	9,796,167
General and administrative	4,847,126	4,328,838
Research and development expense - milestone		5,000,000
Total operating expenses	13,236,513	19,125,005
Loss from operations	(13,140,885)	(18,586,507)
Other (expense)/income:
Gain on forgiveness of PPP loan	421,584
Foreign currency transaction loss	(39,361)	(23,385)
Interest expense	(862,577)	(10,882)
Research and development incentives	174,770	95,359
Other income	30,754
Total other (expense)/income	(274,830)	61,092
Net loss before income taxes	(13,415,715)	(18,525,415)
Income tax benefit	864,742	836,893
Net loss applicable to common stockholders	$ (12,550,973)	$ (17,688,522)
Basic net loss per share (per share)	$ (0.31)	$ (0.64)
Diluted net loss per share (per share)	$ (0.31)	$ (0.64)
Basic weighted average common shares outstanding (in shares)	40,132,182	27,486,949
Diluted weighted average common shares outstanding (in shares)	40,132,182	27,486,949
Contract revenue
Revenues:
Total revenues	$ 33,351	$ 1,930,533
Grant revenue
Revenues:
Total revenues	$ 790,917	$ 428,914